HGH Fragment 176-191 – Hilma Boicare – Powder – 5mg/vial

GHRP-6 – Hilma Boicare – Powder – 10mg/vial
January 22, 2019
PEG MGF – Hilma Boicare – Powder – 2mg/vial
January 22, 2019
Show all

HGH Fragment 176-191 – Hilma Boicare – Powder – 5mg/vial

44.00

The range of Peptides Hilma Biocare is developed according to high quality standards. The advanced Hilma Biocare technology provides 176% Fragment 191-99.10 peptide.

Description

The HGH Fragment is a modified form of amino acids 176-191 at the C-terminal region of the human growth hormone (HGH). Studies have shown that it works by mimicking the way natural HGH regulates fat metabolism but without the adverse effects on insulin sensitivity (blood sugar) or cell proliferation (muscle growth) that is seen with unmodified HGH. Like unmodified GH, the HGH fragment 176-191 stimulates lipolysis (breaking down of fat) and inhibits lipogenesis (the formation of fatty acids and other lipids in the body).HGH fragment 176-191 is meant to be 12.5 times stronger than human growth hormone (HGH) for weight loss than standard human growth hormone (HGH).Of particular note is that in studies HGH fragment 176-191 had the ability to increase IGF-1 levels which translates into the fragments ability to give anti-aging effects.

We ship this product in the following countries in 7 to 15 business days on average:

3

We pay particular attention to the packaging and delivery of all your products. Each expedition is treated with the utmost care. All our products are reconditioned under vacuum to ensure protection, sterility and above all unparalleled discretion. We ship the products with their original packaging and instructions.

We send you your tracking number immediately after sending your package and you can track your package via the carrier’s website (we send you all the information by email with your tracking number).

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “HGH Fragment 176-191 – Hilma Boicare – Powder – 5mg/vial”

Your email address will not be published. Required fields are marked *

EnglishFrench